| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/11/2006 | WO2006050458A2 Tadalafil crystal forms and processes for preparing them |
| 05/11/2006 | WO2006050435A1 Heterocyclical chromophore architectures |
| 05/11/2006 | WO2006050162A2 Imidazole derivatives |
| 05/11/2006 | WO2006049890A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 05/11/2006 | WO2006049880A1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 05/11/2006 | WO2006049339A1 Novel fused imidazole derivative |
| 05/11/2006 | WO2006049013A1 Compound containing fused ring and organic electroluminescent element employing the same |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | WO2006048425A1 Process for making a non-nucleoside hiv-1 reverse transcriptase inhibitor |
| 05/11/2006 | WO2006018279A3 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 05/11/2006 | WO2005101838A8 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 05/11/2006 | WO2005058893A8 Tricyclic benzimidazoles |
| 05/11/2006 | WO2005051317A3 Substituted imidazo ring systems and methods |
| 05/11/2006 | WO2005018551A3 Oxime substituted imidazo-containing compounds |
| 05/11/2006 | WO2005012275A3 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
| 05/11/2006 | WO2003091253A8 Nitrosated imidazopyridines |
| 05/11/2006 | US20060100436 Antimicrobial quinolones, their compositions, and uses |
| 05/11/2006 | US20060100427 Alzheimer's disease and other diseases relating to amyloid deposits; neurodegenerative diseases |
| 05/11/2006 | US20060100249 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100234 Gastric protection and gastric acid secretion-inhibitors; antiulcer agents; acid reflux, Zollinger-Ellison syndrome, heartburn and peptic ulcer bleeding; e.g. methyl 8-(2,3-dihydro-2-hydroxy-1-indenylamino)-2,3- dimethyl-imidazo(1,2a)pyridine-6-carboxylate |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100230 Indolin phenylsulfonamide derivatives |
| 05/11/2006 | US20060100229 Pyrazolopyridines and analogs thereof |
| 05/11/2006 | US20060100218 Phosphodiesterase 4; asthma, chronic obstructive pulmonary disease, Alzheimer's disease, diffuse large-cell B cell lymphoma, and chronic lymphocytic leukemia; 8-[3-(3,4-dimethoxy-phenyl)-pyrrolo[2,3-b]pyridine-1-sulfonyl]-quinoline |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100203 Fungicides based on nitrogen-containing heterocycles |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation |
| 05/11/2006 | US20060099638 incorporating indolium ring moiety substituted at 3-position improves spectral properties; for detection of ligands; hybridization probes |
| 05/11/2006 | US20060097227 Excellent as an electron transporting layer as well as a light emitting layer; can be prepared by using a vacuum evaporation process, casting process or the like; devices having a large area can be prepared easily at a relatively low cost |
| 05/11/2006 | DE102004054216A1 Substituierte 4-Amino-pyridopyrimidinone Substituted 4-amino-pyridopyrimidinone |
| 05/11/2006 | DE102004054215A1 Pyridopyrimidinonderivate Pyridopyrimidinonderivate |
| 05/11/2006 | CA2586259A1 Novel fused imidazole derivative |
| 05/11/2006 | CA2585967A1 Substituted indolizines and derivatives as cns agents |
| 05/11/2006 | CA2585934A1 Novel pyrazolopyridine urea kinase inhibitors |
| 05/11/2006 | CA2585925A1 Tetrahydro-pyridinyl pyrazole cannabinoid modulators |
| 05/11/2006 | CA2585544A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 05/11/2006 | CA2584869A1 Heterocyclical chromophore architectures |
| 05/11/2006 | CA2582092A1 Tadalafil crystal forms and processes for preparing them |
| 05/11/2006 | CA2581255A1 Process for making a non-nucleoside hiv-1 reverse transcriptase inhibitor |
| 05/10/2006 | EP1655301A1 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| 05/10/2006 | EP1655300A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/10/2006 | EP1655028A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 05/10/2006 | EP1654262A1 7-azaindole derivatives as cox2 inhibitors |
| 05/10/2006 | EP1654238A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653961A1 Inhibitors of akt activity |
| 05/10/2006 | EP1653959A2 Lipid-modified immune response modifiers |
| 05/10/2006 | EP1653955A2 Hydroxylamine substituted imidazo-containing compounds |
| 05/10/2006 | EP1653946A2 Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein kinase inhibitors |
| 05/10/2006 | EP1653914A2 Oxime substituted imidazo-containing compounds |
| 05/10/2006 | EP1497290A4 Process for preparing acid salts of gemifloxacin |
| 05/10/2006 | EP1412354B1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 05/10/2006 | EP1228376B1 Fluorescent compounds for use in industrial water systems |
| 05/10/2006 | EP1049700B9 Chemokine receptor antagonists and methods of use therefor |
| 05/10/2006 | CN1771231A Calcium receptor modulating compound and use thereof |
| 05/10/2006 | CN1771038A Vitamin comprising pyroloquinoline quinone and use thereof |
| 05/10/2006 | CN1770980A Pyrazoles and methods of making and using the same |
| 05/10/2006 | CN1769287A Method for producing pyridine derivatives |
| 05/10/2006 | CN1768745A Agents for improving excretory potency of urinary bladder |
| 05/10/2006 | CN1255407C Substituted 3,4-dihydro-pyrido [1,2-a] pyrimidines |
| 05/10/2006 | CN1255405C Substituted pyrazoles |
| 05/10/2006 | CN1255404C Process for preparing substituted imidazopyridine compound |
| 05/10/2006 | CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 05/10/2006 | CN1255402C Intermediates for the production of quinolone carboxylic acid derivatives |
| 05/10/2006 | CN1255386C Substituted fused heterocyclic compounds |
| 05/10/2006 | CN1255364C Method for reducing N oxo-compound |
| 05/09/2006 | US7041835 (−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 05/09/2006 | US7041828 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041827 Phenyl-substituted imidazopyridines |
| 05/09/2006 | US7041819 Separation technology, environmental remediation, and biomedical applications such as dialysis and drug delivery |
| 05/09/2006 | US7041696 Induce inflammation, immunology response; autoimmune disease; antiarthritic agents |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041683 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan |
| 05/09/2006 | US7041675 Invention also relates to the tautomeric forms, and possible enantiomeric and diastereomeric forms of said compounds, to the prodrugs thereof and to their use as PARP inhibitors. |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
| 05/09/2006 | CA2238430C Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/09/2006 | CA2233666C Heterocyclic fungicides |
| 05/04/2006 | WO2006047574A1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/04/2006 | WO2006047528A2 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 05/04/2006 | WO2006047017A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/04/2006 | WO2006046774A1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions |
| 05/04/2006 | WO2006046082A1 A process for the preparation of risperidone |
| 05/04/2006 | WO2006046024A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 05/04/2006 | WO2006046023A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | WO2006031878A3 Imidazoquinoline compounds |
| 05/04/2006 | WO2006018718A3 Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| 05/04/2006 | WO2006010040A3 Antibacterial agents |
| 05/04/2006 | WO2006005726A3 Heterocyclic compounds |
| 05/04/2006 | WO2005123731A3 Pyrrolopyridine derivatives and their use as crth2 antagonists |
| 05/04/2006 | WO2005100353A8 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists |
| 05/04/2006 | WO2005061475A3 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 05/04/2006 | WO2005049581A8 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | US20060094750 1-(cyclopropylmethyl)-2-(2,2-dimethylpropyl)-5-(isopropylsulfonyl)-1H-benzimidazole; for treatment of condition mediated by CB2 receptors; less toxicity, good absorption, distribution, solubility, metabolic stability, less protein binding affinity other than CB2 receptor, less drug-drug interaction |